Artificial Organ Technology market in terms of revenue is expected to grow at CAGR of 10.1% from 2018 to 2025 - PowerPoint PPT Presentation

View by Category
About This Presentation
Title:

Artificial Organ Technology market in terms of revenue is expected to grow at CAGR of 10.1% from 2018 to 2025

Description:

Artificial Organ Technology Market | Major Players are Biomet Inc., Baxter International Inc., Esko Bionics, Gambo AB among others – PowerPoint PPT presentation

Number of Views:18
Date added: 9 June 2020
Slides: 6
Provided by: sheeranalyticsandins

less

Write a Comment
User Comments (0)
Transcript and Presenter's Notes

Title: Artificial Organ Technology market in terms of revenue is expected to grow at CAGR of 10.1% from 2018 to 2025


1
Artificial Organ Technology Market Major
Players are Biomet Inc., Baxter International
Inc., Esko Bionics, Gambo AB among others Global
Artificial Organ Technology market in terms of
revenue is expected to grow at CAGR of 10.1
from 2018 to 2025, as per new market research
report titled Global Artificial Organ Technology
Market (by-product- artificial liver, artificial
pancreas, artificial heart, artificial kidney,
bionic limbs, and others. By technology-
prosthetics and bionics.) Global industry
analysis, size, share, growth, trends, and
forecast, 2017 2025, by Sheer Analytics
Insights Pvt. Ltd. The artificial organ is a kind
of synthetic tissue that is transplanted into
the human body for replacing a natural organ
which is already damaged. This artificial organ
duplicates its specific function thus helping the
patients to return to their natural self as
sooner as possible. The artificial organ
technology and its use have helped the patients
in their search for the donors. The advent of
artificial organ technology has lessened the
need for the donors. The purpose of such
technology is to prevent immediate death
alongside improving the patients health. Browse
Full report on Global Artificial Organ Technology
Market report at https//www.sheeranalyticsandins
ights.com/market-report- research/global-artifici
al-organ-technology-market-21 The Global
Artificial Organ Technology market is projected
to have speedy growth with the rise of the
geriatric population, organ failures, scarcity
of donors, and higher motor related accidents.
These are not
2
only the reason behind the market growth but are
also the key factors for the Global Artificial
Organ Technology market and its growth. Another
driving factor is the increasing public awareness
about the medical advancements. Additionally,
this market also includes the transplantation of
the vital body organs such as the liver, heart,
pancreas, and kidney. For other organs like ears,
eyes, exoskeletons, and brains, the market is
known as the bionics market. Among all the global
regions, the North American region holds the
largest market share in the Global Artificial
Organ Technology market. the only reason behind
this is that North Americans are technically more
advanced and could also afford such expensive
treatments. This type of artificial organ
replacement technology also has a massive impact
on the Asia Pacific market. Growing population
with an increase in different types of kidney,
liver and heart diseases is creating an immense
growth opportunity in the Asia Pacific and other
European regions owing to the rapid advancements
of the healthcare units. In the recent market
research reports that were published by Sheer
Analytics Insights, the global artificial organ
technology market has been classified on the
basis of its products and technology. The major
products of the global artificial organ
technology market include artificial pancreas,
artificial liver, artificial heart, bionic limbs,
artificial kidney, and others. On the basis of
its technology, the market is divided prosthetics
and bionics. The global market is also further
bifurcated into geographical regions like North
America, Middle East Africa, Asia- Pacific,
and Latin America. Medtronic, Incorporated
received approval for its latest medical
technology- the Guardian Sensor 3. The Guardian
Sensor 3 controls
3
  • insulin delivery via the MiniMed 670G system, a
    hybrid closed looped system. This sensor is for
    people aged 14 and above with Type 1 diabetes.
    The Guardian Sensor 3 ensures a consistent and
    steadfast performance required for powering the
    MiniMed 670G system by incorporating diagnostic
    technology which monitors sensor health
    continuously.
  • Alejandro Galindo, president of the Intensive
    Insulin Management division within the Diabetes
    Group at Medtronic said, "We are steadfast in
    our commitment to delivering both best-in-class
    clinical outcomes as well as best-in-class
    experiences for our customers. We are inspired by
    the many voices in the diabetes community who
    continue to shape our offerings in a meaningful
    way as we work to address the wide spectrum of
    needs within the community. We are very pleased
    to offer this added flexibility for those who
    rely on our therapies for their diabetes
    management needs."
  • List of Companies Covered
  • Biomet Inc.,
  • Baxter International Inc.,
  • Esko Bionics,
  • Gambo AB, among others.
  • Global Artificial Organ Technology Market and its
    segmentation By Product Type
  • Artificial Liver
  • Artificial Pancreas
  • Artificial Heart

4
  • Artificial Kidney
  • Bionic Limbs
  • Others
  • By Technology Type
  • Prosthetics
  • Bionics
  • By Geography Type
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
  • To know more about this study, request a free
    sample report _at_ https//www.sheeranalyticsandinsi
    ghts.com/request- sample/2/1/96/5
  • About Us
  • Sheer Analytics and Insights as firm is created
    to balance between client requirements without
    compromising the core values of Market research
    in terms of quality, factual correctness,
    market awareness and analysis. SAI goes back to
    the root of Market Research in terms of TAM
    (Total Available Market) and PAM (Potential
    Available Market) and assess the same quantifying
    all Push and Pull factors.

5
Contact us Name Abhigyan Sengupta (Global
sales Manager) Ph - 91-33-4600-9199 RDB
Boulevard, 8th Floor, Plot K 1, Sector 5, Block
EP and GP, Kolkata 700091, India. Email
sales_at_sheeranalyticsandinsights.com Website
https//www.sheeranalyticsandinsights.com/
About PowerShow.com